FTC targets ‘Pharma Bro’ Martin Shkreli over start-up

24-01-2023

Muireann Bolger

FTC targets ‘Pharma Bro’ Martin Shkreli over start-up

DCStockPhotography / Shutterstock.com

Commission holds that the convicted former pharma head may have violated his life-long ban from working in the life sciences industry | Shkreli is already convicted of conspiring to illegally increase the price of a life-saving drug.


FTC, Martin Shkreli, startup, life sciences, US District Court for the Southern District of New York, Daraprim, generics

LSIPR